- 专利标题: Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
-
申请号: US12763939申请日: 2010-04-20
-
公开(公告)号: US10231933B2公开(公告)日: 2019-03-19
- 发明人: F. Joseph Daugherty , John R. Palmer , Michael S. Tempesta
- 申请人: F. Joseph Daugherty , John R. Palmer , Michael S. Tempesta
- 申请人地址: US NE Omaha
- 专利权人: CRYXA LLC
- 当前专利权人: CRYXA LLC
- 当前专利权人地址: US NE Omaha
- 主分类号: A61K31/198
- IPC分类号: A61K31/198 ; A61K9/28 ; A61K9/16
摘要:
An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.